Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Hospital Medicine
|
January 16, 2007
Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient
Luci Leykum, Jacqueline Pugh, David Diuguid, et al.
The American Journal of Medicine
|
December 31, 2008
Worth a second look
David Goldberg, Ilan Weisberg, David Diuguid, et al.
Journal of Critical Care
|
September 14, 2015
Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
Daryl Glick, Amy L Dzierba, Darryl Abrams, et al.
The Annals of Thoracic Surgery
|
October 9, 2017
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Chia-Ling Lee, Paolo C Colombo, Andrew Eisenberger, et al.
Blood Advances
|
June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Holger J Schünemann, et al.
Blood Advances
|
February 9, 2021
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
September 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
May 3, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
October 22, 2024
American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary
Deborah M Siegal, Eric K Tseng, Holger J Schünemann, et al.
Blood Advances
|
November 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Hospital Medicine
|
January 16, 2007
Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient
Luci Leykum, Jacqueline Pugh, David Diuguid, et al.
The American Journal of Medicine
|
December 31, 2008
Worth a second look
David Goldberg, Ilan Weisberg, David Diuguid, et al.
Journal of Critical Care
|
September 14, 2015
Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
Daryl Glick, Amy L Dzierba, Darryl Abrams, et al.
The Annals of Thoracic Surgery
|
October 9, 2017
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Chia-Ling Lee, Paolo C Colombo, Andrew Eisenberger, et al.
Blood Advances
|
June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Holger J Schünemann, et al.
Blood Advances
|
February 9, 2021
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
September 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
May 3, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
October 22, 2024
American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary
Deborah M Siegal, Eric K Tseng, Holger J Schünemann, et al.
Blood Advances
|
November 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Page
of 1